TNT With FLOT/Durvalumab Plus Post-OP Durvalumab for Resectable Gastroesophageal Adenocarcinoma

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
TNT With FLOT/Durvalumab Plus Post-OP Durvalumab for Resectable Gastroesophageal Adenocarcinoma	Esophagogastric Adenocarcinoma	Not yet recruiting	Phase 2	2026-04-02		NCT07507968

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
AstraZeneca	806
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest	34

29 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Caritas Klinikum Saabrücken	Saarbrücken	Germany	1
Charité Berlin	Berlin	Germany	5
HOPE Hamburg Eppendorf	Hamburg	Germany	1
Hospital Clínico Universitario de Valencia Servicio de Oncología Médica	Valencia	Spain	1
Hospital General Universitari Vall d'Hebron (HUVH)	Barcelona	Spain	1
Hospital Regional Universitario de Jaén	Jaén	Spain	1
Hospital Regional Universitario de Málaga	Málaga	Spain	13
Hospital Universitari Germans Trias i Pujol	Badalona	Spain	9
Hospital Universitario Central de Asturias. Oncología Médica	Oviedo	Spain	1
Hospital Universitario de Navarra (HUN)	Pamplona	Spain	1
Hospital Universitario Miguel Servet Oncología Médica	Zaragoza	Spain	1
Hospital Universitario Virgen de las Nieves de Granada	Granada	Spain	1
Klinikum Essen Mitte	Essen	Germany	1
Krankenhaus Nordwest	Frankfurt am Main	Germany	2
Marien Hospital Herne	Herne	Germany	3
NCT Heidelberg	Heidelberg	Germany	2
Nürnberg Klinikum Nord	Nuremberg	Germany	1
RKH Klinikum Ludwigsburg	Ludwigsburg	Germany	1
TU München	München	Germany	1
UKE Hamburg	Hamburg	Germany	5
Universitätsklinikum Halle (Saale)	Halle	Germany	5
Universitätsklinikum Köln	Cologne	Germany	13
Universitätsklinikum Leipzig	Leipzig	Germany	22
Universitätsklinikum Marburg	Marburg	Germany	3
Universitätsklinikum Ulm	Ulm	Germany	25

Clinical trials